Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials
Background: Antihypertensive treatment may have different effects on central arterial hemodynamics. The extent of the difference in effects between various antihypertensive drugs remains undefined.Methods: We conducted a systematic review and meta-analysis of randomized controlled trials that explor...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/adade729c17842929a5b2bf57e3432a4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:adade729c17842929a5b2bf57e3432a4 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:adade729c17842929a5b2bf57e3432a42021-11-30T18:30:31ZAntihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials1664-042X10.3389/fphys.2021.762586https://doaj.org/article/adade729c17842929a5b2bf57e3432a42021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphys.2021.762586/fullhttps://doaj.org/toc/1664-042XBackground: Antihypertensive treatment may have different effects on central arterial hemodynamics. The extent of the difference in effects between various antihypertensive drugs remains undefined.Methods: We conducted a systematic review and meta-analysis of randomized controlled trials that explored the effects of antihypertensive agents on both central and peripheral systolic blood pressure (SBP) and pulse pressure (PP) or central augmentation index, with a special focus on the comparison between newer [renin-angiotensin-aldosterone system (RAS) inhibitors and calcium-channel blockers (CCBs)] and older antihypertensive agents (diuretics and β- and α-blockers).Results: In total, 20 studies (n = 2,498) were included. Compared with diuretics (10 studies), β-blockers (16 studies), or an α-blocker (1 study), RAS inhibitors (21 studies), and CCBs (6 studies) more efficaciously (P < 0.001) reduced both central and peripheral SBP by a weighted mean difference of −5.63 (−6.50 to −4.76 mmHg) and −1.97 mmHg (−2.99 to −0.95 mmHg), respectively. Compared with older agents, the newer agents also more efficaciously (P < 0.001) reduced central PP (−3.27 mmHg; −4.95 to −1.59 mmHg), augmentation index (−6.11%; −7.94 to −4.29) and augmentation (−3.35 mmHg; −5.28 to –1.42 mmHg) but not peripheral PP (p ≥ 0.09). Accordingly, the newer agents reduced central-to-peripheral PP amplification significantly less than the older agents (0.11 mmHg; 0.05 to 0.17 mmHg; P < 0.001).Conclusion: Newer agents, such as RAS inhibitors and CCBs, were significantly more efficacious than older agents in their effects on central hemodynamics.Yi-Bang ChengJia-Hui XiaYan LiJi-Guang WangFrontiers Media S.A.articleantihypertensive treatmentcentral blood pressureaugmentation indexrandomized controlled trialdrugPhysiologyQP1-981ENFrontiers in Physiology, Vol 12 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
antihypertensive treatment central blood pressure augmentation index randomized controlled trial drug Physiology QP1-981 |
spellingShingle |
antihypertensive treatment central blood pressure augmentation index randomized controlled trial drug Physiology QP1-981 Yi-Bang Cheng Jia-Hui Xia Yan Li Ji-Guang Wang Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials |
description |
Background: Antihypertensive treatment may have different effects on central arterial hemodynamics. The extent of the difference in effects between various antihypertensive drugs remains undefined.Methods: We conducted a systematic review and meta-analysis of randomized controlled trials that explored the effects of antihypertensive agents on both central and peripheral systolic blood pressure (SBP) and pulse pressure (PP) or central augmentation index, with a special focus on the comparison between newer [renin-angiotensin-aldosterone system (RAS) inhibitors and calcium-channel blockers (CCBs)] and older antihypertensive agents (diuretics and β- and α-blockers).Results: In total, 20 studies (n = 2,498) were included. Compared with diuretics (10 studies), β-blockers (16 studies), or an α-blocker (1 study), RAS inhibitors (21 studies), and CCBs (6 studies) more efficaciously (P < 0.001) reduced both central and peripheral SBP by a weighted mean difference of −5.63 (−6.50 to −4.76 mmHg) and −1.97 mmHg (−2.99 to −0.95 mmHg), respectively. Compared with older agents, the newer agents also more efficaciously (P < 0.001) reduced central PP (−3.27 mmHg; −4.95 to −1.59 mmHg), augmentation index (−6.11%; −7.94 to −4.29) and augmentation (−3.35 mmHg; −5.28 to –1.42 mmHg) but not peripheral PP (p ≥ 0.09). Accordingly, the newer agents reduced central-to-peripheral PP amplification significantly less than the older agents (0.11 mmHg; 0.05 to 0.17 mmHg; P < 0.001).Conclusion: Newer agents, such as RAS inhibitors and CCBs, were significantly more efficacious than older agents in their effects on central hemodynamics. |
format |
article |
author |
Yi-Bang Cheng Jia-Hui Xia Yan Li Ji-Guang Wang |
author_facet |
Yi-Bang Cheng Jia-Hui Xia Yan Li Ji-Guang Wang |
author_sort |
Yi-Bang Cheng |
title |
Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials |
title_short |
Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials |
title_full |
Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials |
title_fullStr |
Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials |
title_full_unstemmed |
Antihypertensive Treatment and Central Arterial Hemodynamics: A Meta-Analysis of Randomized Controlled Trials |
title_sort |
antihypertensive treatment and central arterial hemodynamics: a meta-analysis of randomized controlled trials |
publisher |
Frontiers Media S.A. |
publishDate |
2021 |
url |
https://doaj.org/article/adade729c17842929a5b2bf57e3432a4 |
work_keys_str_mv |
AT yibangcheng antihypertensivetreatmentandcentralarterialhemodynamicsametaanalysisofrandomizedcontrolledtrials AT jiahuixia antihypertensivetreatmentandcentralarterialhemodynamicsametaanalysisofrandomizedcontrolledtrials AT yanli antihypertensivetreatmentandcentralarterialhemodynamicsametaanalysisofrandomizedcontrolledtrials AT jiguangwang antihypertensivetreatmentandcentralarterialhemodynamicsametaanalysisofrandomizedcontrolledtrials |
_version_ |
1718406401637744640 |